New $50m plant unveiled by Kyowa Hakko Kirin
July 12, 2011Manufacturing and Production Kyowa Hakko Kirin, pharma manufacturing news
Japan’s Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in …
OctoPlus wins Danish development, manufacturing contract
July 12, 2011Manufacturing and Production OctoPlus, pharma manufacturing news
Dutch drug delivery specialist OctoPlus has been awarded a contract with an unidentified Danish drugmaker based on its microsphere technology. …
Lonza buys Arch Chemicals for $1.2 billion
July 12, 2011Manufacturing and Production Lonza, pharma manufacturing news
Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …
Takeda forced to withdraw Actos in France
July 11, 2011Sales and Marketing Actos, Competact, Takeda, diabetes
Takeda has officially taken its diabetes drug Actos off the market in France at the request of the country’s medicines …
Cadila plant in India gets FDA warning
July 11, 2011Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news
Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …
Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost
July 11, 2011Sales and Marketing Lipitor, Pfizer, paediatric trials
Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …
Sanofi sells dermatology unit for $425m
July 11, 2011Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi, Valeant, dermatology
Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …
Lousia Roberts and Ralph Torbay join Idea Pharma
July 11, 2011Sales and Marketing appointment, sales and marketing
Idea Pharma has two new additions to its team, appointing Louisa Roberts and Ralph Torbay. Louise joins the phase II …
Novartis’ Votubia reduces benign brain tumours in SEGA patients
July 11, 2011Research and Development Novartis, SEGA, Votubia, everolimus
Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …
Kantar Health Names Werner Guminski CEO, Commercial Strategy
July 8, 2011Business Services, Research and Development Kantar Health, commercial strategy
Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …
Publicis Life Brands Resolute boosts team
July 8, 2011Medical Communications appointment, medical communications, medical communications news, publicis
London-based healthcare communications agency Publicis Life Brands Resolute has boosted its Creative and Digital division with four new appointments. They …
Ferring relocates to new UK headquarters
July 8, 2011Sales and Marketing Ferring, UK pharma
Ferring Pharmaceuticals has moved its UK operations from Slough to new facilities just outside London in West Drayton. The Swiss …
Lilly chief: German reforms jeopardise pharma innovation
July 8, 2011Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing
German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …
Pfizer sharpens its pharma focus
July 8, 2011Sales and Marketing Pfizer, animal health, nutrition, pharma strategy
Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …
Eurocom wins healthcare services account
July 7, 2011Medical Communications Eurocom, medical communications agency, medical communications news
Eurocom Healthcare Communications has been appointed to develop a strategic marketing communications programme for a UK healthcare services company. Malling …
Working Life: Sanofi’s oncology franchise director
July 7, 2011Business Services, Sales and Marketing Working Life, careers, recruitment
Sanofi’s oncology franchise director Neale Harris talks to Pharmafocus about how his field is changing and offers some advice for …
Working through the ‘ZOUD’
July 7, 2011Business Services, Research and Development, Sales and Marketing careers, management, recruitment
Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …
BMS licences potential first-in-class cancer biologic
July 7, 2011Research and Development BMS, Cancer, biologics
Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …
Former Sanofi-Pasteur MSD president joins board at Genticel
July 6, 2011Research and Development appointment, research and development
Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
